Abstract
The world’s two largest beer manufacturers, Anheuser-Busch InBev (AB InBev) and SABMiller, have agreed in principle to merge. AB InBev, the Belgium based producer of global brands such as Budweiser, Corona, and Stella Artois will acquire London based SABMiller, brewer of Peroni, Miller, and Grolsch. At £70bn (€100bn; $106bn) this would be the third largest deal in corporate history, establishing a dominant position in the global beer market. Its completion depends on navigating the regulatory demands of competition policy in multiple jurisdictions. Yet the real importance of the deal is what it symbolises for the future of the global alcohol industry. Here we focus on its implications for the growing epidemic of alcohol related harm across low and middle income countries.
Original language | English |
---|---|
Article number | h6087 |
Number of pages | 2 |
Journal | BMJ |
Volume | 351 |
DOIs | |
Publication status | Published - 17 Nov 2015 |
Keywords
- alcohol industry
- company merger
- public health
- policy
- alcohol
- drinks industry
- tobacco